Financials

Ideas Discussions Technicals Seasonals

ZHYBF fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Zhong Yuan Bio-Technology Holdings Ltd. engages in the research and development of early detection kits for brain diseases, plant-derived nervonic acid health supplements and new drugs for neurological diseases. It also develops new drugs to treat cognitive impairment, brain atrophy and other encephalopathies caused by brain white matter damage. The company was founded on April 4, 2016 and is headquartered in Hong Kong.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

ZHYBF has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company